Malignant Neoplasm of Breast

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Selumetinib and Olaparib in Solid Tumors

Swedish Ibrance Registries Insights (SIRI)

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

Ibrance Real World Insights

Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer

Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

Low-field MRI for Breast Cancer Screening

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)